In one inbred strain of laboratory mice, late-life treatment with a GLP-1 drug extends lifespan. This effect might be more than just a consequence of calorie restriction.
02 September 2026
In one inbred strain of laboratory mice, late-life treatment with a GLP-1 drug extends lifespan. This effect might be more than just a consequence of calorie restriction.
By
Maria Emilia Fernandez
Maria Emilia Fernandez is in the Experimental Gerontology Section and Translational Gerontology Branch, National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224, USA.
A glucagon-like peptide-1 (GLP-1) receptor agonist prescribed to help people manage obesity and type 2 diabetes extended the…
Older female mice given an anti-obesity medication lived longer and in better health than did mice not taking one.
Semaglutide treatment for 3 months in female mice improved physiological function, attenuated hallmarks of ageing and modulated…
Giving old mice semaglutide—commonly sold as Wegovy or Ozempic—extends their lifespan remarkably, a new study finds
GLP-1 drugs help fight the harmful inflammation that raises the risk of chronic disease
Without careful study design, studies in which the use of GLP-1 receptor agonists such as semaglutide lowered calorie intake…
The drugs found to slow down ageing - and you might already be taking them
